MicroRNA-146a rs2910164 polymorphism is associated with susceptibility to non-small cell lung cancer in the Chinese population

Medical Oncology

Volumn 31, Issue 10, 2014, Pages 1-5

  Jia, Youchao ^a   Zang, Aimin ^a   Shang, Yanhong ^a   Yang, Hua ^a   Song, Zizheng ^a   Wang, Zhiyu ^a   Ren, Lili ^a   Wei, Yaning ^a   Hu, Ling ^a   Shi, Hongyun ^a   Li, Hefei ^a  

^a HEBEI UNIVERSITY   (China)

Author keywords

MiR 146a; NSCLC; Polymorphism

Indexed keywords

MICRORNA 146A; MICRORNA; MIRN146 MICRORNA, HUMAN;

ADULT; ALLELE; ARTICLE; CANCER PATIENT; CANCER SUSCEPTIBILITY; CANCER TISSUE; CHINESE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG PARENCHYMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON SMALL CELL LUNG CANCER; POLYMERASE CHAIN REACTION; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING HABIT; SQUAMOUS CELL LUNG CARCINOMA; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS;

ADULT; AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; REAL-TIME POLYMERASE CHAIN REACTION; RISK FACTORS;

EID: 84906454520     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-014-0194-2     Document Type: Article

References (19)

1. Dutt A, Ramos AH, Hammerman PS, Mermel C, Cho J, Sharifnia T, et al. Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer. PLoS one. 2011;6(6):e20351.
2. Wistuba II. Genetics of preneoplasia: lessons from lung cancer. Curr Mol Med. 2007;7(1):3–14.
3. Cortinovis D, Monica V, Pietrantonio F, Ceresoli G, La Spina, Wannesson L. MicroRNAs in Non-Small Cell Lung Cancer: Current Status and Future Therapeutic Promises. Curr Pharm Des. 2014;20(24):3982–90.
4. Jakopovic M, Thomas A, Balasubramaniam S, Schrump D, Giaccone G, Bates SE. Targeting the Epigenome in Lung Cancer: expanding Approaches to Epigenetic Therapy. Front Oncol. 2013;3:261.
5. Schabath MB, Giuliano AR, Thompson ZJ, Amankwah EK, Gray JE, Fenstermacher DA, et al. TNFRSF10B polymorphisms and haplotypes associated with increased risk of death in non-small cell lung cancer. Carcinogenesis. 2013;34(11):2525–30.
6. Ren YW, Yin ZH, Wan Y, Guan P, Wu W, Li XL, et al. P53 Arg72Pro and MDM2 SNP309 Polymorphisms Cooperate to Increase Lung Adenocarcinoma Risk in Chinese Female Non-smokers: a Case Control Study. Asian Pac J Cancer Prev. 2013;14(9):5415–20.
7. Loktionov A. Common gene polymorphisms, cancer progression and prognosis. Cancer Lett. 2004;208(1):1–33.
8. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA. 2004;101(9):2999–3004.
9. Ryan BM, Robles AI, Harris CC. Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer. 2010;10(6):389–402.
10. Akkız H, Bayram S, Bekar A, Akgöllü E, Usküdar O, Sandıkçı M. No association of pre-microRNA-146a rs2910164 polymorphism and risk of hepatocellular carcinoma development in Turkish population: a case–control study. Gene. 2011;486(1–2):104–9.
11. Qiu LX, He J, Wang MY, Zhang RX, Shi TY, Zhu ML, et al. The association between common genetic variant of microRNA-146a and cancer susceptibility. Cytokine. 2011;56(3):695–8.
12. Jeon HS, Lee YH, Lee SY, Jang JA, Choi YY, Yoo SS, et al. A common polymorphism in pre-microRNA-146a is associated with lung cancer risk in a Korean population. Gene. 2014;534(1):66–71.
13. Vinci S, Gelmini S, Pratesi N, Conti S, Malentacchi F, Simi L, et al. Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers. Clin Chem Lab Med. 2011;49(12):2073–80.
14. Ye Y, Wang KK, Gu J, Yang H, Lin J, Ajani JA, et al. Genetic variations in microRNA-related genes are novel susceptibility loci for esophageal cancer risk (Phila). Cancer Prev Res. 2008;1:460–9.
15. Xu T, Zhu Y, Wei QK, Yuan Y, Zhou F, Ge YY, et al. A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma. Carcinogenesis. 2008;29:2126–31.
16. Jazdzewski K, Liyanarachchi S, Swierniak M, Pachucki J, Ringel MD, Jarzab B, et al. Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer. Proc Natl Acad Sci USA. 2009;106:1502–5.
17. Hurst DR, Edmonds MD, Scott GK, Benz CC, Vaidya KS, Welch DR. Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Res. 2009;69:1279–83.
18. Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR, de la Chapelle A. Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci USA. 2008;105:7269–74.
19. Yoon KA, Yoon H, Park S, Jang HJ, Zo JI, Lee HS, Lee JS. The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer. J Thorac Cardiovasc Surg. 2012;144(4):794–807.